Pathway-Based Drug Repositioning for Breast Cancer Molecular Subtypes
Breast cancer is a major public health problem which treatment needs new pharmacological options. In the last decades, during the postgenomic era new theoretical and technological tools that give us novel and promising ways to address these problems have emerged. In this work, we integrate several t...
Saved in:
Main Authors: | Raúl A. Mejía-Pedroza (Author), Jesús Espinal-Enríquez (Author), Enrique Hernández-Lemus (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2018-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Spatio-Temporal Representativeness of Air Quality Monitoring Stations in Mexico City: Implications for Public Health
by: Karol Baca-López, et al.
Published: (2021) -
Cytofluorometric characteristics of molecular subtypes of breast cancer
by: L. K. Tsoi, et al.
Published: (2014) -
Molecular Subtypes of Breast Cancer Are Not Associated with the Clinical Under- or Overstaging of Breast Cancer
by: Juliana Pinho Espinola, et al.
Published: (2016) -
Downstream Signaling of Inflammasome Pathway Affects Patients' Outcome in the Context of Distinct Molecular Breast Cancer Subtypes
by: Concetta Saponaro, et al.
Published: (2022) -
Drug Repositioning in Glioblastoma: A Pathway Perspective
by: Sze Kiat Tan, et al.
Published: (2018)